Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy.
Algohary A, Alhusseini M, Breto AL, Kwon D, Xu IR, Gaston SM, Castillo P, Punnen S, Spieler B, Abramowitz MC, Dal Pra A, Kryvenko ON, Pollack A, Stoyanova R. Algohary A, et al. Among authors: xu ir. Cancers (Basel). 2022 Sep 15;14(18):4475. doi: 10.3390/cancers14184475. Cancers (Basel). 2022. PMID: 36139635 Free PMC article.
Deep Learning for Per-Fraction Automatic Segmentation of Gross Tumor Volume (GTV) and Organs at Risk (OARs) in Adaptive Radiotherapy of Cervical Cancer.
Breto AL, Spieler B, Zavala-Romero O, Alhusseini M, Patel NV, Asher DA, Xu IR, Baikovitz JB, Mellon EA, Ford JC, Stoyanova R, Portelance L. Breto AL, et al. Among authors: xu ir. Front Oncol. 2022 May 18;12:854349. doi: 10.3389/fonc.2022.854349. eCollection 2022. Front Oncol. 2022. PMID: 35664789 Free PMC article.
Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI.
Stoyanova R, Zavala-Romero O, Kwon D, Breto AL, Xu IR, Algohary A, Alhusseini M, Gaston SM, Castillo P, Kryvenko ON, Davicioni E, Nahar B, Spieler B, Abramowitz MC, Dal Pra A, Parekh DJ, Punnen S, Pollack A. Stoyanova R, et al. Among authors: xu ir. Cancers (Basel). 2023 Oct 31;15(21):5240. doi: 10.3390/cancers15215240. Cancers (Basel). 2023. PMID: 37958414 Free PMC article.
Uncovering prostate cancer aggressiveness signal in T2-weighted MRI through a three-reference tissues normalization technique.
Algohary A, Zacharaki EI, Breto AL, Alhusseini M, Wallaengen V, Xu IR, Gaston SM, Punnen S, Castillo P, Pattany PM, Kryvenko ON, Spieler B, Abramowitz MC, Pra AD, Ford JC, Pollack A, Stoyanova R. Algohary A, et al. Among authors: xu ir. NMR Biomed. 2024 Mar;37(3):e5069. doi: 10.1002/nbm.5069. Epub 2023 Nov 21. NMR Biomed. 2024. PMID: 37990759
RExPRT: a machine learning tool to predict pathogenicity of tandem repeat loci.
Fazal S, Danzi MC, Xu I, Kobren SN, Sunyaev S, Reuter C, Marwaha S, Wheeler M, Dolzhenko E, Lucas F, Wuchty S, Tekin M, Züchner S, Aguiar-Pulido V. Fazal S, et al. Genome Biol. 2024 Jan 31;25(1):39. doi: 10.1186/s13059-024-03171-4. Genome Biol. 2024. PMID: 38297326 Free PMC article.
Testing SIPA1L2 as a modifier of CMT1A using mouse models.
Murray GC, Hines TJ, Tadenev ALD, Xu I, Züchner S, Burgess RW. Murray GC, et al. bioRxiv [Preprint]. 2023 Dec 1:2023.11.30.569428. doi: 10.1101/2023.11.30.569428. bioRxiv. 2023. PMID: 38076977 Free PMC article. Updated. Preprint.
A study concept of expeditious clinical enrollment for genetic modifier studies in Charcot-Marie-Tooth neuropathy 1A.
Xu IRL, Danzi MC, Ruiz A, Raposo J, De Jesus YA, Reilly MM, Cortese A, Shy ME, Scherer SS, Herrmann DN, Fridman V, Baets J, Saporta M, Seyedsadjadi R, Stojkovic T, Claeys KG, Patel P, Feely S, Rebelo AP; Inherited Neuropathy Consortium; Dohrn MF, Züchner S. Xu IRL, et al. J Peripher Nerv Syst. 2024 Apr 5. doi: 10.1111/jns.12621. Online ahead of print. J Peripher Nerv Syst. 2024. PMID: 38581130